Overall, the low frequency of MED12 exon 2 mutations in various mesenchymal tumours suggests that the high mutation frequency observed in uterine leiomyomas is not a common feature for all mesenchymal tumours. The gene discussed is MED12; the disease is Uterine leiomyoma.